Over the past decade, human papillomavirus (HPV) vaccinations have prevented thousands of cervical cancer cases worldwide.
Beginning in July 2025, the enhanced 9-valent HPV vaccine will become more available in the Region of the Americas.
The Pan American Health Organization (PAHO) Revolving Fund announced on February 7, 2025, that the general availability of the 9-valent HPV vaccine will be easier and more affordable for Latin American countries.
HPV9 Vaccines Coming to Latin America
2011 to 2023 Saw Increase in Early Adult Mortality in the United States
Early adult excess mortality higher than expected in 2019